Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,648,394

« Back to Dashboard
Patent 5,648,394 protects VANIQA and is included in one NDA.

This patent has twenty-four patent family members in eighteen countries.

Summary for Patent: 5,648,394

Title: Topical composition for inhibiting hair growth
Abstract:The present invention embraces a topical composition for inhibiting mammalian hair growth, particularly human beard hair growth (including hirsutism), comprising a water-soluble, hair-growth-inhibiting agent dispersed in an oil-in-water emulsion in the form of a lotion or cream. The invention also embraces a method of inhibiting mammalian hair growth by applying an effective amount of the above composition to the skin. The invention further embraces a topical composition for delivering a pharmacological agent to the skin.
Inventor(s): Boxall; Brian Alfred (Berkshire RG11 5EU, GB), Amery; Geoffrey Wilfred (Berkshire RG6 1HN, GB), Ahluwalia; Gurpreet S. (Gaithersburg, MD)
Assignee:
Application Number:08/513,980
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent PDF download available with subscription

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Skinmedica
VANIQA
eflornithine hydrochloride
CREAM;TOPICAL021145-001Jul 27, 2000RXYes5,648,394<disabled>TREATMENT OF EXCESSIVE FEMALE FACIAL HAIR
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,648,394

PCT Information
PCT FiledMay 27, 1993PCT Application Number:PCT/US93/05068
PCT Publication Date:September 29, 1994PCT Publication Number: WO94/21217

International Patent Family for Patent: 5,648,394

Country Document Number Publication Date Supplementary Protection Certificate SPC Country SPC Expiration
African Intellectual Property Organization (OAPI)10183Dec 18, 1996
China1093755Nov 06, 2002
Australia4524393Oct 11, 1994
South Africa9403561Jan 26, 1995
Austria172871Nov 15, 1998
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc